BiondVax Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process

Stock Information for Scinai Immunotherapeutics Ltd Sponsed ADR (New)

Loading

Please wait while we load your information from QuoteMedia.